Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. (Q45918280)
Jump to navigation
Jump to search
scientific article published on 28 July 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. |
scientific article published on 28 July 2009 |
Statements
1 reference
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. (English)
1 reference
B Laika
1 reference
S Leucht
1 reference
S Heres
1 reference
H Schneider
1 reference
W Steimer
1 reference
28 July 2009
1 reference
10
1 reference
1
1 reference
20-29
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference